Polymorphisms in Selected Genes and Their Association with Age-Related Macular Degeneration in a Chinese Population
- PMID: 29565837
- PMCID: PMC5877204
- DOI: 10.12659/msm.906298
Polymorphisms in Selected Genes and Their Association with Age-Related Macular Degeneration in a Chinese Population
Abstract
BACKGROUND Increasing evidence shows that polymorphisms in a number of genes can influence age-related macular degeneration (AMD) risk. This study aimed to investigate the association of CX3CR1 839C/T, CX3CR1 745G/A, PLEKHA1 958A/G, VEGFA +674C/T, and VEGFA +936C/T polymorphisms with AMD risk among Chinese. MATERIAL AND METHODS The polymorphisms were genotyped on 827 AMD patients and 827 controls, and the odds ratios (ORs) were calculated under allele, additive, recessive, and dominant genetic models. Logistic regression analysis was performed to control for potential confounders (age, sex, and smoking status). RESULTS We showed that all the 5 polymorphisms showed a significant association with AMD risk under the additive model (for homozygous mutant genotype) and at least 1 other genetic model, both before and after adjustment for the potential confounders. PLEKHA1 958A/G polymorphism was associated with a decreased AMD risk (additive model: aOR=0.722, 95% CI=0.450-0.979, P=0.019; allele model: aOR=0.883, 95% CI=0.736-0.992, P=0.014), while all other polymorphisms were associated with an increased AMD risk (CX3CR1 839C/T, additive model: aOR=2.682, 95% CI=1.119-5.709, P=0.022, recessive model: aOR=2.729, 95% CI=1.141-6.048, P=0.010; CX3CR1 745G/A, additive model: aOR=2.614, 95% CI=1.231-6.012, P=0.020, recessive model: aOR=2.340, 95% CI=1.227-5.993, P=0.011; VEGFA +674C/T, additive model: aOR=1.601, 95% CI=1.253-2.179, P<0.001, dominant model: aOR=1.287, 95% CI=1.058-1.570, P<0.001, allele model: OR=1.220, 95% CI=1.118-1.427, P<0.001; VEGFA +936C/T, additive model: aOR=1.509, 95% CI=1.105-2.311, P<0.001, recessive model: aOR=1.432, 95% CI=1.027-2.192, P=0.009, dominant model: aOR=1.207, 95% CI=1.031-1.514, P0.001, allele model: aOR=1.216, 95% CI=1.062-1.408, P<0.001). CONCLUSIONS We conclude that the 5 polymorphisms could serve as biomarkers for AMD susceptibility.
Conflict of interest statement
None.
Similar articles
-
Study of Polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients.Arch Med Res. 2014 Aug;45(6):489-94. doi: 10.1016/j.arcmed.2014.07.005. Epub 2014 Jul 19. Arch Med Res. 2014. PMID: 25050486
-
CX3CR1 polymorphisms and the risk of age-related macular degeneration.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9592-6. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26464724 Free PMC article.
-
PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population.Mol Vis. 2007 Nov 26;13:2153-9. Mol Vis. 2007. PMID: 18079691
-
Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.Gene. 2019 May 25;698:186-197. doi: 10.1016/j.gene.2019.02.070. Epub 2019 Mar 5. Gene. 2019. PMID: 30849545
-
Association of Two Polymorphisms, rs1061170 and rs1410996, in Complement Factor H with Age-Related Macular Degeneration in an Asian Population: A Meta-Analysis.Ophthalmic Res. 2016;55(3):135-44. doi: 10.1159/000442257. Epub 2016 Jan 5. Ophthalmic Res. 2016. PMID: 26727378 Review.
Cited by
-
Haplotypes of HTRA1 rs1120638, TIMP3 rs9621532, VEGFA rs833068, CFI rs10033900, ERCC6 rs3793784, and KCTD10 rs56209061 Gene Polymorphisms in Age-Related Macular Degeneration.Dis Markers. 2019 Sep 8;2019:9602949. doi: 10.1155/2019/9602949. eCollection 2019. Dis Markers. 2019. PMID: 31583032 Free PMC article.
-
Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review.Front Aging Neurosci. 2021 Mar 18;13:646901. doi: 10.3389/fnagi.2021.646901. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33815092 Free PMC article.
References
-
- Ferrara N. Vascular endothelial growth factor and age-related macular degeneration: From basic science to therapy. Nat Med. 2010;16(10):1107–11. - PubMed
-
- Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16. - PubMed
-
- Gupta D, Gupta V, Singh V, et al. Study of polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients. Arch Med Res. 2014;45(6):489–94. - PubMed
-
- Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14(21):3227–36. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases